MedPath

RAN-LEVETIRACETAM

RAN-LEVETIRACETAM

Discontinued
DIN Number

02396114

Drug Class

Human

Market Date

Mar 22, 2013

Company
HC

ranbaxy pharmaceuticals canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02396114
AIG Number0148843002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVETIRACETAMActive
Strength: 500 MG
Monograph: LEVETIRACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.